Upstream Processing

Jun 07, 2016
By BioPharm International Editors
A new 20,000-L microbial biologics facility in Ireland will be operational by 2018 for Fujifilm Diosynth's contract development and manufacturing customers.
May 01, 2016
BioPharm International
Cell therapy companies are attracting interest from investors, and drug companies are seeking partnerships and acquistions to accelerate development.
May 01, 2016
BioPharm International
Two main safety issues have been identified in the early-phase clinical trials conducted to date for chimeric antigen receptor (CAR)-T cell therapies.
May 01, 2016
BioPharm International
Developers of CAR-T cell therapies with products showing successful early-stage clinical results are currently seeking manufacturing capacity that will enable the production of the larger quantities of material needed for Phase III trials and eventual commercialization.
May 01, 2016
BioPharm International
Early successes drive the need to overcome safety issues, increase efficacy, and address manufacturing challenges.
May 01, 2016
BioPharm International
Data acquired from osmolality, glucose, and folic acid tests provides useful information for the specific identification of cell-culture media.
Apr 27, 2016
By BioPharm International Editors
The company announced the launch of its first-in-class Lynx CDR connectors at INTERPHEX 2016.
Apr 18, 2016
The National Institute of Health will conduct an internal review of the National Cancer Institute’s cell manufacturing facilities, which will affect multiple Kite projects.
Apr 04, 2016
Microchannels show potential benefits for inertial cell sorting and for introducing genetic material into cells.
Apr 01, 2016
BioPharm International
The authors provide application data to support the use of SEC beyond small-scale operations.
native1_300x100
lorem ipsum